Delayed ERK1/2 activation attributed to mitochondrial dysfunction has been reported in acute 6-hydroxydopamine (6-OHDA) and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models of PD [39]. This evidence concerns the gene MAPK3 and Parkinson disease.